— Know what they know.
Not Investment Advice

KRSA NASDAQ

Korsana Biosciences, Inc.
1W: -3.1% 1M: -2.5% 3M: +22.7% YTD: +220.6% 1Y: +102.6% 3Y: +27.9% 5Y: -92.5%
$30.07
-2.02 (-6.29%)
 
Weekly Expected Move ±10.5%
$25 $28 $31 $35 $38
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 47 · $140.8M mcap · 2M float · 2.75% daily turnover · Short 36% of daily vol
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: insufficient price history.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Supply Chain Overview

1 relationships
0
As Filer
counterparties named
1
As Counterparty
mentioned by others
2026-04-01
Earliest Filing
2026-04-01
Latest Filing

Mentioned As Counterparty

1 mentions

Other companies that named KRSA in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
CYCN Cyclerion Therapeutics, Inc. acquirer Target company in the merger agreement with Cyclerion Therapeutics, Inc. 2026-04-01 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-09-11 Material Agreement; Acquisition/Disposition; Earnings Release; Unregistered Equity Sales; Change in Agreement Acquisition View
2026-08-27 Shareholder Vote; Other Events; Exhibits View
2026-08-25 Other Events View
2026-04-01 Material Agreement; Change in Control; Officer/Director Change; Regulation FD; Exhibits Agreement View
2026-02-17 Regulation FD Disclosure; Financial Statements and Exhibits View
2026-01-06 Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit Agreement View
2025-12-01 Other Events View
2025-09-23 Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit Agreement View
2025-06-18 Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits View
2025-05-07 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2025-03-25 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme Agreement View
2024-12-17 Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit Agreement View
2024-08-07 Regulation FD Disclosure; Financial Statements and Exhibits View
2024-06-14 Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits View
2024-04-18 Other Events; Financial Statements and Exhibits View
2023-12-04 Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem View
2023-12-01 Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem View
2023-11-24 Departure/Election of Directors; Appointment of Officers View
2023-10-23 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2023-07-19 Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms